Septum Solutions

ChitoTruss is Now Available!

Better Breathing...Instantly
Septum Solutions' technologies may allow for improved breathing post procedurally and durable long term outcomes.
Learn More
Nasal blockage is difficult
Recovering from corrective surgery shouldn't be.
Our Solutions
Previous slide
Next slide

Septum Solutions is developing a suite of splints & stents that offer considerable advantages over the competition.

Hemostatic

Chitosan-loaded devices aid in minimizing postoperative bleeding*

Antimicrobial

Chitosan-loaded devices provide antimicrobial protection, lowering the risk of infection while facilitating wound healing*

Nasal Obstruction

Nasal Airway Obstruction & Chronic Rhinosinusitis are extremely common diseases with enormous impact on quality of life, the productivity of the workplace, and the annual healthcare spend.  20 million Americans suffer from nasal obstruction, and at least 28.9 million Americans are diagnosed with sinusitis each year (11.6% of Adults), generating over 4.1 million physician visits.

Over 1 million surgical procedures are performed in the US each year to combat these nasal and sinus issues. In addition, an even greater number of cosmetic nasal procedures performed annually

The Septum Solutions Difference

Our Solutions

ChitoTruss

ChitoTruss is a cutting edge solution to address the challenges associated with current nasal splint products in the market. ChitoTruss incorporates a chitosan coating. Chitosan is known to aid the process of minimizing bleeding and infection.

SinoTruss

The SinoTruss family of devices are made of pure chitosan.  These tubular-shaped stents are intended for placement in the sinus openings after surgery to enlarge them. They are designed to dissolve within 3-4 weeks after surgery with routine postoperative nasal saline rinsing.

The Aire line of products provides an all in one solution that includes the SinoTruss and ChitoTruss family of devices that are made of pure chitosan.  

What Our Patients Say

"Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus ullamcorper mattis."
Angelina Vive
Patient
"Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus ullamcorper mattis."
Michael William
Patient

Contact Us

*Radwan-Praglowska J., Piatkowski M., Deineka V., Chitosan-Based Bioactive
Hemostatic Agents with Antibacterial Properties-Synthesis and Characterization.
2019 Jul 19;24(14):2629. doi: 10.3390/molecules24142629. PMID: 31330957

Scroll to Top